Collectively, our findings provide mechanistic insights into how BATF3 regulates hepatic and adipose homeostasis, contributing to fibrosis development, and highlight the BATF3-ANGPTL8 axis as a potential therapeutic target in fatty liver disease. Here, BATF3 is linked to fatty liver disease.